Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.
Publication
, Journal Article
Brinkley-Rubinstein, L; Rosen, DL; Christopher, P; Bazerman, L; Beckwith, CG
Published in: Clin Infect Dis
October 1, 2017
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
October 1, 2017
Volume
65
Issue
7
Start / End Page
1247 / 1248
Location
United States
Related Subject Headings
- Prisons
- Microbiology
- Humans
- HIV Infections
- HIV
- Anti-Retroviral Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brinkley-Rubinstein, L., Rosen, D. L., Christopher, P., Bazerman, L., & Beckwith, C. G. (2017). Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities. Clin Infect Dis, 65(7), 1247–1248. https://doi.org/10.1093/cid/cix493
Brinkley-Rubinstein, Lauren, David L. Rosen, Paul Christopher, Lauri Bazerman, and Curt G. Beckwith. “Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.” Clin Infect Dis 65, no. 7 (October 1, 2017): 1247–48. https://doi.org/10.1093/cid/cix493.
Brinkley-Rubinstein L, Rosen DL, Christopher P, Bazerman L, Beckwith CG. Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities. Clin Infect Dis. 2017 Oct 1;65(7):1247–8.
Brinkley-Rubinstein, Lauren, et al. “Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.” Clin Infect Dis, vol. 65, no. 7, Oct. 2017, pp. 1247–48. Pubmed, doi:10.1093/cid/cix493.
Brinkley-Rubinstein L, Rosen DL, Christopher P, Bazerman L, Beckwith CG. Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities. Clin Infect Dis. 2017 Oct 1;65(7):1247–1248.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
October 1, 2017
Volume
65
Issue
7
Start / End Page
1247 / 1248
Location
United States
Related Subject Headings
- Prisons
- Microbiology
- Humans
- HIV Infections
- HIV
- Anti-Retroviral Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences